info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
in IN: +91-826-083-6500
Home » Injection And Needles »

Hemostats and Tissue Sealants Market: Product Type Topical Hemostat (Mechanical Hemostats (ORC based Topical Hemostats, Collagen-based Topical Hemostats, Gelatin based Topical Hemostats)), (Polysaccharide based Topical Hemostats (Flowable Hemostats, Active Hemostats)), Adhesive and Tissue Sealing Agents (Adhesion Barrier Products, Synthetic Tissue Sealant, Natural Tissue Sealant), By Geography, Segment revenue estimations, Forecast: 2021-2028.

Published On: Dec-2021   |   Base Year: 2020   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 48122689

Introduction: -

In 2020, the valuation of the Global Hemostats and Tissue Sealants Market size was USD 6.35 billion. As per the SMR analysis,the market is set to reach USD 11.27billion by 2028, projecting a CAGR of8.93 percent throughout the forecasted period of 2020-2028.

Hemostats and Sealants are the medical devices implemented to prevent hemorrhage and bleeding caused due to injuries and surgical processes,resulting in progressive healing. The Coagulation system comprises proteins and blood cells responsible for blood clotsleading tohemostasis,platelet plug formation, etc. The tremendous growth in the market is expected due to the risingnumber of surgeries worldwide.Hemophilia or Immune Thrombocytopenia is a disorder where the blood doesn’t clot in a typical way.Hemophilia type A affects 1 in 5,000 male children, and in the United States,The(Hemophilia A) disease affects approximately 400 babies per year. According to the Centers for Disease Control and Prevention (CDC), more than 45% of the population in the United States suffers from at least one chronic condition that requires proper care. Every year, approximately 2 million people die from hemorrhageworldwide, out of which almost 1.5 million deaths are due to physical trauma.In the United States, nearly 60,000 people die from hemorrhagingand blood loss each year.

Global Hemostats and Tissue Sealants Market Impact Under COVID-19:

The outbreak of the COVID-19 pandemic had a considerable impact on the market during the forecasted period. COVID-19 causes thrombotic complications and bleeding, a significant cause of morbidity in patients affected by the virus. D-dimer elevation during admission was predictive of bleeding, critical illness, thrombosis, and death in patients suffering from COVID-19. Thereby the market for Global Hemostats and Tissue Sealants Marketexperienced an upswing during and post Covid-19 outbreak.

 

Market Dynamics: -

Market Drivers: -

  • The introduction of Fibrin Sealant Products has led to a rising prevalence in adhesion prevention, expanded the areas of applications in drug delivery mechanisms, and is fuelling the overall market growth.As a result, the Fibrin Sealant market is growing steadily at a CAGR of 7.23% and will reach USD 1.39 Billion by 2028.

 

Restraints: - High cost of surgical procedures

  • The higher cost of surgical procedures and the lack of reimbursement forhemostats and sealants products are the significant reasons restricting the overall growth of the market. For the patients who are not covered up by health insurance, the cost of brain hemorrhage surgery would pile up to USD 1,50,000 or more.

 

Opportunities: - Increasing prevalence of  MIS (Minimally Invasive Surgeries)

  • The preferences for MIS (Minimally Invasive Surgeries) have increased drastically over the past few years. It is because MIS has a lot of advantages like shorter hospital stays, less recovery time, etc., and is likely to dominate the market in the future resulting in the rise of Global Hemostats and Tissue Sealants Market share.

Global Hemostats And Tissue Sealants Market:- Segmentation Analysis:

The WorldwideHemostasis and Tissue Sealing Agents Marketare broadly segmented based on Product Type, End-User,And Regions.

Based on Product Type

  • Topical Hemostat
  • Mechanical Hemostats

ORC based Topical Hemostats

Collagen-based Topical Hemostats

Gelatin based Topical Hemostats

  • Polysaccharide based Topical Hemostats

Flowable Hemostats

Active Hemostats

  • Adhesive and Tissue Sealing Agents
    • Adhesion Barrier Products
    • Synthetic Tissue Sealant
    • Natural Tissue Sealant

 

Based on End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on Regions

North America

  • US
  • Mexico
  • Canada
  • Rest of North America

 

Europe

  • Switzerland
  • Russia
  • France
  • Germany
  • U.K
  • Finland
  • Turkey
  • Netherlands 
  • Belgium
  • Spain
  • Italy
  • Rest of Europe

 

Asia Pacific

  • China
  • India
  • Japan
  • Malaysia
  • Singapore
  • South Korea
  • Thailand
  • Indonesia
  • Philippines
  • Australia

 

Rest of Asia-Pacific

  • LAMEA
  • Brazil
  • Argentina
  • Uruguay
  • Saudi Arabia
  • Rest of LAMEA

 

Based on Product Type, the ‘Topical Hemostat’ segment dominated the market with a CAGR of 7.13% with a revenue of USD 3.42 billion in 2020and is projected to propel rapidlyover the forecasted period. Topical hemostats play a crucial role in restricting the bleeding in surgical procedures when conventional procedures become ineffective or impractical.

Based on End-User, the ‘Hospitals’ segment dominated the market significantly over the forecasted period due to a higher patient preference for hospitals over other healthcare facilities for hemorrhage treatments. 

Based on Regions, ‘North America’ dominated the market with a steady CAGR of 8.23% due to the rise in in-patient and outpatient surgical procedures and the continuous increase in demand for hemostat products.

Moreover, the Asia Pacific region has the fastest growth with a robust CAGR over the forecasted period due to the steep increase in surgical processes.

 

Global HemostatsAnd Tissue Sealants Market: Competitive Landscape

Competitive landscape analysis is the most crucial factorfor figuring out the notable competitors in the market environment worldwide. Therefore, the comparison is solely performed based on the expenditure in the field of R&D, market capability, global presence, market initiatives, company overview and financials, overall revenue generated,production capacity, production facilities and sites, organization flaws and strengths, etc.

The major players that are mapped and triangulated in the Global Hemostasis and Tissue Sealing Agents Market report are:

  • Advanced Medical Solutions Group plc
  • Baxter
  • Cohera MedicalInc
  • CryoLife Inc
  • C.R. BardInc
  • Integra Life Sciences Corporation
  • Johnson & Johnson ServicesInc
  • Pfizer Inc
  • B Braun Medical Inc
  • Cohesion Technologies Inc

 

Global Hemostats and Tissue Sealants Market: Recent Development: -

  • On15th July, 2021, Baxter supported the analytical demonstration of Clinical& Economic Benefits of Effective Intraoperative Blood Management for Surgical Patients. It demonstrated that the implementation of active hemostatic products would result in lower rates of bleeding-related complications, shorter duration of hospital stays, and decreased hospital expenditures compared to the combined usage of active and passive hemostats.
  • On 05thJuly, 2019, Sangamo and Pizer announce their study result for sb-525 investigational hemophilia a gene therapy showing sustained increase in factor viii levels

 

Frequently Asked Question About This Report

In 2020, the Hemostasis and Tissue Sealing Agents Market sharevalued up toglobal hemostats and tissue sealants market USD 6.35 billion with a CAGR of 8.93% and is estimated to reach a landmark of USD 11.27 billion by 2028.

The most mentionable critical players in the Global Hemostasis and Tissue Sealing Agents Market areBaxter,Advanced Medical Solutions Group plc, Cohera Medical Inc,CryoLife Inc, C.R. Bard Inc, Integra Life Sciences Corporation, Johnson & Johnson Services Inc, Pfizer Inc, B Braun Medical Inc, Cohesion Technologies Inc, etc.

North America dominates in the global Hemostasis and Tissue Sealing Agents Market with an overall CAGR of 8.23% and will continue to do so over the forecasted period.

‘Topical Hemostat’ is the leading product segment in the Global Hemostasis and Tissue Sealing Agents Market.

‘Hospitals’ segment is the leading and dominant End User segment in the Global Hemostasis and Tissue Sealing Agents Market.

In 2020, the United States accounted for the largest market share in the Global Hemostasis and Tissue Sealing Agents Market.

Thrombomodulin, endothelial cells, Microfibrillar collagen, Gelatin sponges, etc., are some of the anti-blood coagulants in the Hemostasis and Tissue Sealing Agents Market world wide.

na

Chapter 1. Introduction

     1.1 Study Objectives

     1.2 Market Definition

            Table 1 Inclusions and Exclusions

     1.3 Study Scope

            1.3.1 Markets Covered

                      Figure 01: Hemostats and Tissue Sealants Market Segmentation

            1.3.2 Geographic Scope

                      Figure 02: Hemostats and Tissue Sealants Market Geography covered

            1.3.3 Years Considered

     1.4 Stakeholders

Chapter 2. Research Methodology

      2.1 Data Procurement

      2.2 Paid Database

             2.2.1 Secondary Data

                       2.2.1.1 Key Secondary sources

             2.2.2 Primary Data

                      2.2.2.1 Primary sources

                      2.2.2.2 Key industry insights

                      2.2.2.3 Primary interviews with experts

                      2.2.2.4 Key primary respondent list

      2.3 Market Size Estimation

      2.4 Bottom-Up and Top-Down Approaches

             2.4.1 Bottom-Up Approach

                       2.4.1.1 Approach for arriving at market size by bottom-up analysis

                                    Figure 03: Hemostats and Tissue Sealants Market: Bottom-Up Approach

             2.4.2 Top-Down Approach

                       2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis

                                    Figure 04: Hemostats and Tissue Sealants Market: Top-Down Approach

        2.5 Market Breakdown and Data Triangulation

               Figure 05: Data Triangulation

         2.6 Research Methodology

         2.7 Risk Assessment

               Table 2: Risk Assessment

Chapter 3. Executive Summary

          3.1 Hemostats and Tissue Sealants Market: Post-Covid-19

                Figure 06: Impact of Covid-19 on Hemostats and Tissue Sealants Market

                          3.1.1 Actual Scenario

                 Figure 07: Realistic Scenario: Hemostats and Tissue Sealants Market, 2020–2028 (USD Million)

                          3.1.2 Pessimistic Scenario

               Figure 08: Pessimistic Scenario: Hemostats and Tissue Sealants Market, 2020–2028 (USD Million)

                          3.1.3 Optimistic Scenario

               Figure 09: Optimistic Scenario: Hemostats and Tissue Sealants Market, 2020–2028(USD Million)

                          3.1.4 Market Summary

                     Figure 10: Topical Hemostat to Witness Highest CAGR in Hemostats and Tissue Sealants Market, By Product Type, During Forecast Period

                     Figure 11: Hospitals Higher CAGR in Hemostats and Tissue Sealants Market for End-User Segment during Forecast Period

                    Figure 12: North America to Account for Largest Share of Global Hemostats and Tissue Sealants Market In 2020

Chapter 4. Market Definitions

      4.1 Market Segmentation

             Figure 13: Hemostats and Tissue Sealants Market Segmentation

Chapter 5. Industry Outlook

      5.1 Market Snapshot

      5.2 Global Hemostats and Tissue Sealants Market

              5.2.1 Global Hemostats and Tissue Sealants market, 2020 – 2028 (USD Million)

      5.3 Regional Segment Analysis

             5.3.1 Global Hemostats and Tissue Sealants market, by region, 2020 - 2028 (USD Million)

      5.4 Product Type Segment Analysis

             5.4.1 Global Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

      5.5 End-User Segment Analysis

             5.5.1 Global Hemostats and Tissue Sealants market, By End-User, 2020 - 2028 (USD Million)

      5.6 Value Chain Analysis

      5.7 Market Variable Analysis

             5.7.1 Market Drivers Analysis

             5.7.2 Market Restraints Analysis

      5.8 Business Environment Analysis Tool

               5.8.1 Hemostats and Tissue Sealants market PEST analysis

               5.8.2 Hemostats and Tissue Sealants market Porter’s analysis

      5.9 Penetration & Growth Prospect Mapping

Chapter 6. Market Overview

     6.1 Introduction

     6.2 Market Dynamics

            Figure 14 Hemostats and Tissue Sealants Market: Drivers, Restraints, Opportunities, and Challenges

                 6.2.1 Drivers

            Figure 15 Hemostats and Tissue Sealants Market Drivers and Their Impact

                 6.2.2 Restraints

            Figure 16 Hemostats and Tissue Sealants Market Restraints and Their Impact

                 6.2.3 Opportunities

            Figure 17 Hemostats and Tissue Sealants Market Opportunities and Their Impact

                 6.2.4 Challenges

            Figure 18 Hemostats and Tissue Sealants Market Challenges and Their Impact

     6.3 Impact of Covid-19 on Hemostats and Tissue Sealants Market

     6.4 Value Chain Analysis

            Figure 19 Value Chain Analysis: Hemostats and Tissue Sealants Market

     6.5 Ecosystem

               Figure 20 Hemostats and Tissue Sealants Market: Ecosystem

Table 3 Hemostats and Tissue Sealants Market: Ecosystem

               Figure 21 Revenue Shift in Hemostats and Tissue Sealants Market

     6.6 Patent Analysis

Table 4 Number of Patents Registered in Hemostats and Tissue Sealants Market in USA in Last 9 Years

                Figure 22 Top 10 Companies with Highest No. of Patents in Last 9 Years

                Figure 23 No of Patents Granted Per Year, 2019–2020

Table 5 List of Global Patents in Hemostats and Tissue Sealants Market

     6.7 Trade Analysis

     6.8 Tariff Analysis

     6.9 Case Study Analysis

     6.10 Porter’s Five Forces Analysis

Table 6: Hemostats and Tissue Sealants Market: Porter’s Five Forces Analysis, 2020

             6.10.1 Threat of New Entrants

             6.10.2 Threat of Substitutes

             6.10.3 Bargaining Power of Buyers

             6.10.4 Bargaining Power of Suppliers

             6.10.5 Degree of Competition

     6.11 Technology Analysis

             6.11.1 Trends in Technology (2014-2020)

             6.11.2 Trends in Technology (2021-2028)

                    Table 7 Key Regulations: Hemostats and Tissue Sealants Market

     6.12 Pricing Analysis

              6.12.1 Average Price Trend Analysis (By region, By Countries)

Chapter 7. Competitive & Vendor Landscape

     7.1 Company Market Share Analysis

                   Table 8: Key Players market share

             Figure 24: Key players market share of companies

     7.2 Manufacturers Hemostats and Tissue Sealants Manufacturing Sites, Area Served, Product Product Type

     7.3 Hemostats and Tissue Sealants Market Competitive Situation and Trends

     7.4 Manufacturers Mergers & Acquisitions, Expansion Plans

Chapter 8. Global Hemostats and Tissue Sealants Market: Product Type Segment Analysis

     8.1 Introduction

     8.2 Sales Volume & Revenue Analysis (2020-2028)

                    Table 9 Hemostats and Tissue Sealants Market, By Product Type, 2021–2028 (USD Million)

            Figure 25 Hemostats and Tissue Sealants Market, By Product Type

            Figure 26 Topical Hemostat Segment to Register Highest CAGR in Hemostats and Tissue Sealants Market During Forecast Period

     8.3 Topical Hemostat

            8.3.1 Topical Hemostat market, 2020 - 2028 (USD Million)

               8.3.1.1 Mechanical Hemostats market, 2020 - 2028 (USD Million)

            8.3.2 ORC based Topical Hemostats market, 2020 - 2028 (USD Million)

            8.3.3 Collagen-based Topical Hemostats market, 2020 - 2028 (USD Million)

            8.3.4 Gelatin based Topical Hemostats market, 2020 - 2028 (USD Million)

                8.3.4.1 Polysaccharide based Topical Hemostats market, 2020 - 2028 (USD Million)        

            8.3.5 Flowable Hemostats market, 2020 - 2028 (USD Million)

            8.3.6 Active Hemostats market, 2020 - 2028 (USD Million)

Figure 27: Topical Hemostat market, 2020 - 2028 (USD Million)

     8.4 Adhesive and Tissue Sealing Agents

            8.4.1 Adhesive and Tissue Sealing Agents market, 2020 - 2028 (USD Million)

               8.4.1.1 Adhesion Barrier Products market, 2020 - 2028 (USD Million)

               8.4.1.2 Synthetic Tissue Sealant market, 2020 - 2028 (USD Million)

               8.4.1.3 Natural Tissue Sealant market, 2020 - 2028 (USD Million)

            Figure 28: Adhesive and Tissue Sealing Agents market, 2020 - 2028 (USD Million)

Chapter 9. Global Hemostats and Tissue Sealants Market: End-User Segment Analysis

     9.1 Introduction

     9.2 Sales Volume & Revenue Analysis (2020-2028)

                   Table 10: Hemostats and Tissue Sealants Market, By End-User, 2021–2028 (USD Million)

           Figure 29: Hemostats and Tissue Sealants Market, By End-User, 2021–2028 (USD Million)

           Figure 30: Hospitals Segment to Register Highest CAGR in Hemostats and Tissue Sealants Market during Forecast Period

     9.3 Hospitals

            9.3.1 Hospitals market, 2020 - 2028 (USD Million)

            Figure 31: Hospitals market, 2020 - 2028 (USD Million)

     9.4 Ambulatory Surgical Centers

           9.4.1 Ambulatory Surgical Centers market, 2020 - 2028 (USD Million)

           Figure 32: Ambulatory Surgical Centers market, 2020 - 2028 (USD Million)

     9.5 Specialty Clinics

           9.5.1 Specialty Clinics market, 2020 - 2028 (USD Million)

           Figure 33: Specialty Clinics market, 2020 - 2028 (USD Million)

Chapter 10. Global Hemostats and Tissue Sealants Market: Regional Outlook

     10.1 North America

              Figure 34: North America Hemostats and Tissue Sealants Market, By Revenue Forecast (2020-2028)

              10.1.1 North America Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

                      Table 11: North America Hemostats and Tissue Sealants Market, by Country, 2020-2028

              Figure 35: North America Hemostats and Tissue Sealants Market

              10.1.2 North America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                       Table12: North America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

               Figure 36: North America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

               10.1.3 North America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

                     Table 13: North America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 37: North America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              10.1.4 U.S.

                          10.1.4.1 U.S. Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 38: U.S. Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                           10.1.4.2 U.S. Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 39: U.S. Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

             10.1.5 Canada

                           10.1.5.1 Canada Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

               Figure 40: Canada Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                           10.1.5.2 Canada Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

               Figure 41: Canada Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

               Figure 42: Canada Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

               Figure 43: Canada Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.2 Europe

              Figure 44: Europe Hemostats and Tissue Sealants Market, By Revenue Forecast (2020-2028)

              10.2.1 Europe Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

                             Table 14: Europe Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

              Figure 45: Europe Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

              10.2.2 Europe Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                             Table 15: Europe Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 46: Europe Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             10.2.3 Europe Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

                             Table 16: Europe Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 47: Europe Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

    10.2.4 U.K.

                          10.2.4.1 U.K. Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 48: U.K. Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          10.2.4.2 U.K. Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 49: U.K. Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.2.5 Germany

                          10.2.5.1 Germany Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 50: Germany Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          10.2.5.2 Germany Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 51: Germany Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.2.6 France

                          10.2.6.1 France Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 52: France Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          10.2.6.2 France Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 53: France Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.2.7 Rest of Europe

                          10.2.7.1 Rest of Europe Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 54: Rest of Europe Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          10.2.7.2 Rest of Europe Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 55: Rest of Europe Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.3 Asia Pacific

              Figure 56: Asia Pacific Hemostats and Tissue Sealants Market, By Revenue Forecast (2020-2028)

              10.3.1 Asia Pacific Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

                          Table 17: Asia Pacific Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

              Figure 57: Asia Pacific Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

              10.3.2 Asia Pacific Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          Table 18: Asia Pacific Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 58: Asia Pacific Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             10.3.3 Asia Pacific Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

                         Table 19: Asia Pacific Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

             Figure 59: Asia Pacific Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.3.4 China

                         10.3.4.1 China Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             Figure 60: China Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                         10.3.4.2 China Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

             Figure 61: China Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

    10.3.5 India

                         10.3.5.1 India Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 62: India Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                          10.3.5.2 India Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 63: India Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)                      

     10.3.6 Japan

                         10.3.6.1 Japan Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 64: Japan Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                               10.3.6.2 Japan Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 65: Japan Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.3.7 South Korea

                           10.3.7.1 South Korea Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

               Figure 66: South Korea Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                           10.3.7.2 South Korea Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

               Figure 67: South Korea Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

    10.3.8 Rest of APAC

                         10.3.8.1 Rest of APAC Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 68: Rest of APAC Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                         10.3.8.2 Rest of APAC Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 69: Rest of APAC Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.4 Latin America

              Figure 70: Latin America Hemostats and Tissue Sealants Market, By Revenue Forecast (2020-2028)

             10.4.1 Latin America Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

                         Table 20: Latin America Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

             Figure 71: Latin America Hemostats and Tissue Sealants market, by country, 2020 - 2028 (USD Million)

             10.4.2 Latin America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                         Table 21: Latin America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             Figure 72: Latin America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             10.4.3 Latin America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

                         Table 22: Latin America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

             Figure 73: Latin America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)            

     10.4.4 Brazil

                       10.4.4.1 Brazil Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

            Figure 74: Brazil Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                       10.4.4.2 Brazil Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

            Figure 75: Brazil Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.4.5 Mexico

                        10.4.5.1 Mexico Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

            Figure 76: Mexico Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                         10.4.5 2 Mexico Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

            Figure 77: Mexico Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)                        

     10.4.6 Rest of the Latin America

                        10.4.6.1 Rest of the Latin America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

             Figure 78: Rest of the Latin America Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

                         10.4.6.2 Rest of the Latin America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 79: Rest of the Latin America Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

     10.5 MEA

              Figure 80: MEA Hemostats and Tissue Sealants Market, By Revenue Forecast (2020-2028)

              10.5.1 MEA Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              Figure 81: MEA Hemostats and Tissue Sealants market, by Product Type, 2020 - 2028 (USD Million)

              10.5.2 MEA Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

              Figure 82: MEA Hemostats and Tissue Sealants market, by End-User, 2020 - 2028 (USD Million)

Chapter 11. Competitive Landscape

     11.1 Advanced Medical Solutions Group plc.

             11.1.1 Company overview

             11.1.2 Financial performance

             11.1.3 Product Portfolio Analysis

             11.1.4 Business Strategy & Recent Development

     11.2 Baxter.

             11.2 .1 Company overview

             11.2 .2 Financial performance

             11.2 .3 Product Portfolio Analysis

             11.2 .4 Business Strategy & Recent Development

     11.3 Cohera MedicalInc.

             11.3.1 Company overview

             11.3.2 Financial performance

             11.3.3 Product Portfolio Analysis

             11.3.4 Business Strategy & Recent Development

     11.4 CryoLife Inc.

             11.4.1 Company overview

             11.4.2 Financial performance

             11.4.3 Product Portfolio Analysis

             11.4.4 Business Strategy & Recent Development

     11.5 C.R. BardInc.

             11.5.1 Company overview

             11.5.2 Financial performance

             11.5.3 Product Portfolio Analysis

             11.5.4 Business Strategy & Recent Development

     11.6 Integra Life Sciences Corporation.

             11.6.1 Company overview

             11.6.2 Financial performance

             11.6.3 Product Portfolio Analysis

             11.6.4 Business Strategy & Recent Development

     11.7 Johnson & Johnson ServicesInc.

             11.7.1 Company overview

             11.7.2 Financial performance

             11.7.3 Product Portfolio Analysis

             11.7.4 Business Strategy & Recent Development

     11.8 Pfizer Inc.

             11.8.1 Company overview

             11.8.2 Financial performance

             11.8.3 Product Portfolio Analysis

             11.8.4 Business Strategy & Recent Development

     11.9 B Braun Medical Inc.

             11.9.1 Company overview

             11.9.2 Financial performance

             11.9.3 Product Portfolio Analysis

             11.9.4 Business Strategy & Recent Development

     11.10 Cohesion Technologies Inc.

             11.10.1 Company overview

             11.10.2 Financial performance

             11.10.3 Product Portfolio Analysis

             11.10.4 Business Strategy & Recent Development